The Most Highly Cited Publications from Seminars in Thrombosis and Hemostasis: A Data Analysis 50 Years in the Making
Emmanuel J. Favaloro
DOI: https://doi.org/10.1055/s-0043-1775756
2023-09-29
Seminars in Thrombosis and Hemostasis
Abstract:Welcome to another editorial relating to our celebration of 50 years of publishing for Seminars in Thrombosis & Hemostasis (STH). As noted several times previously, 2024 marks the 50th birthday of STH, which first published in 1974.[1] A half-century of publishing is a landmark worthy of celebration. We started the celebrations in 2022, when we published our first 50th year celebratory issue.[2] A second celebratory issue was published in 2023,[3] and a third compilation was published as the first issue of 2024.[4] All issues were rich in content of a historical nature related to the fields of thrombosis and hemostasis. We plan to prepare a 4th and final 50th year celebratory compilation later in this year. In the interim, we plan to publish a separate tribute to the rich history of STH in each issue of STH publishing in 2024. For the first issue of 2024, we republished the first paper ever published in STH, on the molecular structure of fibrinogen,[5] together with an accompanying commentary from Neerman-Arbez and Casini.[6] In the next few issues of STH, we will republish the most highly cited publications from STH of all time, as also accompanied by commentaries from experts in these specific featured fields. This editorial is accompanying the second issue of STH for 2024 and provides two tables that outline the most highly cited papers from STH. [Table 1] identifies the 100 manuscripts that have been most highly cited over the entire publication history of STH, starting from the first paper published in 1974.[5] These papers have a citation count of 119 or more. Naturally, in such a listing, papers published earlier in the STH publication timeline have considerable advantage in terms of overall citations compared to more recent publications. However, this is still an important analysis for our journal. I would like to make a few comments on this listing. First, three of the papers on the top 100 list were authored by the founding editor in chief of STH, Eberhard F. Mammen. This included two papers on the platelet function analyzer (PFA)-100.[7] [8] It is likely that these papers helped the manufacturer obtain regulatory approvals for clinical use of the PFA-100 in hemostasis laboratories. Another paper on the PFA-100, the first full report to describe the instrument,[9] is understandably also a highly cited paper, listing third on the table. Another paper on the PFA-100 in [Table 1] is my own contribution,[10] written as a tribute to Eberhard Mammen, following his passing in 2008.[11] [12] STH has published several more recent publications mentioning the PFA-100, including its recent remodeling as the PFA-200.[13] [14] [15] Rank Citation Publication year 1 Baskurt OK, Meiselman HJ. Blood rheology and hemodynamics. Semin Thromb Hemost. 2003 Oct;29(5):435–450. 2003 2 Rodgers RP, Levin J. A critical reappraisal of the bleeding time. Semin Thromb Hemost. 1990 Jan;16(1):1–20. 1990 3 Kundu SK, Heilmann EJ, Sio R, Garcia C, Davidson RM, Ostgaard RA. Description of an in vitro platelet function analyzer–PFA-100. Semin Thromb Hemost. 1995;21 Suppl 2:106–112. 1995 4[b] Mammen EF, Comp PC, Gosselin R, Greenberg C, Hoots WK, Kessler CM, Larkin EC, Liles D, Nugent DJ. PFA-100 system: a new method for assessment of platelet dysfunction. Semin Thromb Hemost. 1998;24(2):195–202. 1998 5 Linhardt RJ, Gunay NS. Production and chemical processing of low molecular weight heparins. Semin Thromb Hemost. 1999;25 Suppl 3:5–16. 1999 6 Jurk K, Kehrel BE. Platelets: physiology and biochemistry. Semin Thromb Hemost. 2005;31(4):381–392. 2005 7 Boccardo P, Remuzzi G, Galbusera M. Platelet dysfunction in renal failure. Semin Thromb Hemost. 2004 Oct;30(5):579–589. 2004 8 Hellgren M. Hemostasis during normal pregnancy and puerperium. Semin Thromb Hemost. 2003 Apr;29(2):125–130. 2003 9 Caprini JA, Arcelus JI, Hasty JH, Tamhane AC, Fabrega F. Clinical assessment of venous thromboembolic risk in surgical patients. Semin Thromb Hemost. 1991;17 Suppl 3:304–312. 1991 10 Nagy JA, Chang SH, Shih SC, Dvorak AM, Dvorak HF. Heterogeneity of the Tumor Vasculature. Semin Thromb Hemost. 2010 Apr;36(3):321–331. 2010 11 Finkelstein JD. Pathways and regulation of homocysteine metabolism in mammals. Semin Thromb Hemost. 2000;26(3):219–225. 2000 12 Savi P, Herbert JM. Clopidogrel and ticlopidine: P2Y12 adenosine diphosphate-receptor antagonists for the prevention of atherothrombosis. Semin Thromb Hemost. 2005 Apr;31(2):174–183. 2005 13[b] Mammen EF, Koets MH, Washington BC, Wolk LW, Brown JM, Burdick M, Selik NR, Wilson RF. Hemostasis changes during cardiopulmonary bypass surgery. Semin Thromb Hemost. 1985 Jul;11(3):281–292. 1985 14 Schrör K. Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis. Semin Thromb Hemost. 1997;23(4):349–356. 1997 15 Tschoep -Abstract Truncated-
peripheral vascular disease,hematology